A theme involving production of active pharmaceutical ingredients for generic drugs changing from the Tokyo Machida Plant to the Toyama Yatsuo Plant, thereby establishing the production structure and earnings base of the API business. This also includes revenue growth in the API business accompanying increased sales of the company's own products and products supplied by other companies.